US Stock MarketDetailed Quotes

ENDPQ Endo International

Watchlist
  • 0.000300
  • -0.001500-83.33%
15min DelayTrading Apr 16 09:54 ET
70.57KMarket Cap0.00P/E (TTM)

About Endo International Company

Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.

Company Profile

SymbolENDPQ
Company NameEndo International
Listing DateJul 18, 2000
Founded2013
CEOMr. Blaise A. Coleman
MarketPink Market
Employees2931
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressMinerva House,Simmonscourt Road,1st Floor, Ballsbridge
CityDublin
ProvinceDublin
CountryIreland
Zip Code4
Phone353-1-268-2000

Company Executives

  • Name
  • Position
  • Salary
  • Blaise A. Coleman
  • Director, President and Chief Executive Officer
  • 7.17M
  • Mark G. Barberio
  • Non Executive Chairman of the Board
  • 380.00K
  • Dr. Nancy J. Hutson, PhD
  • Director
  • 400.00K
  • Dr. Mary Christine Smith, PhD
  • Director
  • 161.97K
  • Jennifer Chao
  • Director
  • --
  • William P. Montague
  • Director
  • 405.00K
  • Shane M. Cooke
  • Director
  • 405.00K
  • Michael Hyatt
  • Director
  • 400.00K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg